rs138791086
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_152393.4(KLHL40):c.1273G>A(p.Gly425Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,613,998 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_152393.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLHL40 | NM_152393.4 | c.1273G>A | p.Gly425Ser | missense_variant | 2/6 | ENST00000287777.5 | NP_689606.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLHL40 | ENST00000287777.5 | c.1273G>A | p.Gly425Ser | missense_variant | 2/6 | 1 | NM_152393.4 | ENSP00000287777.4 |
Frequencies
GnomAD3 genomes AF: 0.000809 AC: 123AN: 152070Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000963 AC: 242AN: 251234Hom.: 1 AF XY: 0.000957 AC XY: 130AN XY: 135860
GnomAD4 exome AF: 0.00116 AC: 1693AN: 1461810Hom.: 4 Cov.: 32 AF XY: 0.00115 AC XY: 835AN XY: 727214
GnomAD4 genome AF: 0.000808 AC: 123AN: 152188Hom.: 0 Cov.: 31 AF XY: 0.000780 AC XY: 58AN XY: 74382
ClinVar
Submissions by phenotype
Nemaline myopathy 8 Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 12, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 03, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The KLHL40 p.Gly425Ser variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs138791086) and ClinVar (classified as uncertian significance by Invitae). The variant was identified in control databases in 271 of 282578 chromosomes (1 homozygous) at a frequency of 0.000959 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Other in 14 of 7224 chromosomes (freq: 0.001938), Latino in 52 of 35432 chromosomes (freq: 0.001468), European (non-Finnish) in 182 of 128968 chromosomes (freq: 0.001411), East Asian in 8 of 19944 chromosomes (freq: 0.000401), African in 8 of 24916 chromosomes (freq: 0.000321), European (Finnish) in 4 of 25116 chromosomes (freq: 0.000159) and South Asian in 3 of 30616 chromosomes (freq: 0.000098), but was not observed in the Ashkenazi Jewish population. The p.Gly425 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 30, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 21, 2019 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1273G>A (p.G425S) alteration is located in exon 2 (coding exon 2) of the KLHL40 gene. This alteration results from a G to A substitution at nucleotide position 1273, causing the glycine (G) at amino acid position 425 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at